La cadena de opciones muestra datos clave de las opciones de acciones de Ainos a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Ainos..

Ainos (NASDAQ:AIMD) Bolsa, Cadena de Opciones

Ainos

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Ainos Inc

WIIM

SGMO

Sangamo shares are trading lower after the company announced its collaboration and license agreement with Pfizer on giroctocogene fitelparvovec will terminate effective April 21, 2025.

Brazilian assets are stumbling into the new year as skepticism over President Luiz Inácio Lula da Silva's fiscal repair skills <a href="https://www.benzinga.com/topic/brazil">continues to grow</a>.
What Happened: The Brazilian real has dropped nearly 22% against the U.S. dollar this year, according to <a href="https://www.bloomberg.com/news/articles/2024-12-30/brazil-leads-global-losses-in-2024-as-fiscal-angst-takes-hold?srnd=homepage-americas&amp;sref=TBDibEcD">Bloomberg</a>.
The country&#8217;s central bank, which spent some $20 billion in reserves over the course of two weeks to boost the currency, met again on Monday and sold about $1.8 billion in a spot sale.
The real briefly perked up by just 0.4%, while government bond yields hit heights not seen since former Brazilian President Dilma Rousseff was removed from office in 2016. 
Also, the Ibovespa equity index, the benchmark stock market index for the Brazilian Stock Exchange, is lagging behind almost all major peers.
See Also: <a href="https://www.benzinga.com/news/global/24/12/42562850/brazilian-real-plunges-as-investors-doubt-president-lulas-budget-initiatives">Brazilian Real Plunges As Investors Doubt President Lula&#8217;s Budget Initiatives</a>
Why It Matters: Lula da Silva's budget deficit has ballooned to a whopping 10% of gross domestic product. In other words, Brazil&#8217;s government is spending significantly more than it earns in revenue.
This is not just a Brazilian problem. Emerging markets, for the most part, are currently grappling with <a href="https://www.benzinga.com/24/12/42677388/chinas-squid-game-inspired-scams-target-financially-distressed-amid-economic-slowdown">China's sputtering economy</a>, <a href="https://www.benzinga.com/24/12/42719521/asia-and-europe-markets-mixed-natural-gas-jumps-10-oil-stable-on-demand-hopes-gold-slips-global-markets-today-while-us-slept">geopolitical drama</a>, and the wildcard of U.S. President-elect Donald Trump's <a href="https://www.benzinga.com/government/regulations/24/12/42701155/made-in-china-paid-in-america-what-trumps-new-tariffs-mean-for-the-us-economy">upcoming policies</a>. 
Lula da Silva, who took office in 2023, does not have broad support. Pew Research <a href="https://www.pewresearch.org/global/2024/09/23/brazilians-views-of-lula-and-bolsonaro/">estimates</a> that 48% of Brazilians have a positive view of the 79-year-old politician.
It&#8217;s unclear whether his pick for central bank chief, Gabriel Galipolo, will improve his favorability. Galípolo will begin his term as president of the Central Bank of Brazil on Jan. 1.
Brazilian equities are tracked by the iShares MSCI Brazil ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWZ#NYSE">EWZ</a>), which jumped by 0.42% at last check Monday afternoon.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/econ-s/24/12/42561549/fed-slashes-interest-rates-by-0-25-as-predicted-december-dot-plot-flags-only-2-potential-cuts-in-2025" target="_blank" rel="noreferrer noopener">Fed Slashes Interest Rates By 0.25% As Predicted: December Dot Plot Flags Only 2 Potential Cuts In 2025</a></li>
</ul>
Image: Shutterstock

Latin America

News

Politics

Global

Brazil Central Bank Fails To Impress As Real Slides Further: Report

AFBI

Trading Halt: Halted at 4:25:00 p.m. ET - Trading Halt: Halt News Pending

Sangamo believes that its recently announced partnerships with Genentech and Astellas, and advanced business development discussions for its Fabry gene therapy program, will allow it to chart a path forward for its neurology genomic medicine pipeline as it prepares to initiate expected enrollment of patients in the Phase 1/2 study of ST-503 for idiopathic small fiber neuropathy in mid-2025, and file an anticipated Clinical Trial Authorisation (CTA) submission for the prion disease program in Q4 2025, each subject to securing adequate additional funding.
Based on positive results from Phase 3 AFFINE trial, which met primary and secondary endpoints, Sangamo plans to explore all options to commercialize the asset, including seeking a potential new collaboration partner.
 &nbsp;

Sangamo Says Collaboration, License Agreement With Pfizer On Giroctocogene Fitelparvovec Will Terminate Effective April 21, 2025; Plans To Explore All Options To Commercialize The Asset, Including Seeking Potential New Partner

<a href="https://www.ftc.gov/news-events/news/press-releases/2024/12/ftc-refers-case-against-online-cash-advance-firm-dave-inc-department-justice" title="https://www.ftc.gov/news-events/news/press-releases/2024/12/ftc-refers-case-against-online-cash-advance-firm-dave-inc-department-justice">https://www.ftc.gov/news-events/news/press-releases/2024/12/ftc-refers-case-against-online-cash-advance-firm-dave-inc-department-justice</a>

Legal

DAVE

FTC Refers Case Against Online Cash Advance Firm Dave Inc. to Department of Justice

Sangamo Therapeutics Reveals Pfizer's Decision To Terminate  Global Collaboration And License Agreement Between The Parties; Sangamo To Regain Full Rights to Hemophilia A Gene Therapy Program

Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) reported quarterly sales of $18.10 million which beat the analyst consensus estimate of $16.39 million by 10.43 percent. This is a 7.10 percent increase over sales of $16.90 million the same period last year.

Earnings

Earnings Beats

CETX

Cemtrex Q4 Sales $18.10M Beat $16.39M Estimate

Television host Jim Cramer is known for his outlandish takes on the stock market and his often back-and-forth recommendations that can quickly change day to day and week to week. Cramer has also provided the same back-and-forth recommendations on the cryptocurrency sector <a href="https://www.benzinga.com/crypto">in recent years.</a>
Here&#8217;s a look back at one of Cramer&#8217;s warning calls against cryptocurrency in 2022 and how you could&#8217;ve profited betting against him.
What Happened: Throughout 2024, Cramer has provided <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42205579/jim-cramer-says-bitcoin-and-ethereum-deserve-a-spot-in-your-portfolio-as-hedge-against-rising-us-debt-ive-liked-crypto-for-a-very-long-time">mostly bullish commentary</a> on major cryptocurrencies like Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), suggesting there is room in portfolios for crypto exposure.
The bullishness is likely helped by the approval of Bitcoin ETFs in 2024 and the new <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41778425/bitcoins-all-time-high-a-groundbreaking-milestone-and-strong-post-election-rally-coming-ex">White House administration</a> creating optimism for Bitcoin and cryptocurrency overall going forward.
Cramer was one of many television personalities who dunked on cryptocurrency as the sector struggled with a series of bankruptcies and very public negative catalysts like the collapse of FTX and arrest of Sam Bankman-Fried.
On Dec. 23, 2022, CNBC host Cramer once again criticized the cryptocurrency market and gave a warning to anyone who was investing in the sector. The comments came as it was announced that FTX co-founder Sam Bankman-Fried had been released from jail on $250 million bail.
Cramer said the SEC should be more involved in the cryptocurrency market, noting that when investors look at a filing of a stock, they know who owns it, whereas with cryptocurrency, investors don&#8217;t know who owns them.
The CNBC host&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/22/12/29981089/jim-cramer-says-crypto-is-a-gigantic-con-why-he-sold-bitcoin-ethereum-near-the-top-1" target="_blank" rel="noreferrer noopener">previously owned cryptocurrency</a>&nbsp;before selling all of it, a decision he said he announced on television and doesn&#8217;t regret.
&#8220;I would not touch crypto in a million years,&#8221; Cramer&nbsp;<a href="https://www.youtube.com/watch?v=FIubWYMyrYE&amp;t=1s" target="_blank" rel="noreferrer noopener">said&nbsp;</a>during the Dec. 23, 2022, broadcast.
Cramer said the cryptocurrency sector has fought regulation and investors often see losses of their money.
&#8220;I like to have my money at JPMorgan and I check on Monday to see whether my balance is there.&#8221;
Cramer said the same can&#8217;t be said for cryptocurrency due to volatility and from his personal experience it can be tough to get your money out.
An on-screen graphic showed the prices for Bitcoin, Ethereum, Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), Litecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ltc/usd">LTC</a>) and the cryptocurrency exchange Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>).
The chart and names of several of the cryptocurrencies prompted an angry rant from Cramer.
&#8220;I do think you&#8217;re an idiot. I did not go to college to get stupid. These people who own these things should not own them.&#8221;
Cramer went on to say that cryptocurrencies are the &#8220;creation of money by cretins.&#8221;
&#8220;These are worse than even the worst Nasdaq stocks.&#8221;
When Cramer made his argument in December, investors could have purchased the individual cryptocurrencies and Coinbase stock themselves.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42466189/trump-talks-stocks-bitcoin-ai-economy-with-jim-cramer-youre-going-to-see-some-very-good-days-ahead">Trump Talks Stocks, Bitcoin, AI, Economy With Jim Cramer: &#8216;You&#8217;re Going To See Some Very Good Days Ahead&#8217;</a>
Investing $1,000 in Crypto: An investor who went against Cramer&#8217;s advice on Bitcoin and invested in the leading cryptocurrency on Dec. 23, 2022, would likely be smiling today.
A $1,000 investment at the intraday high could have purchased 0.0592 BTC. The $1,000 investment would be worth $5,577.76 today based on a price of $94,218.86 at the time of writing. This marks a return of +457.8% over the last two years.
The same $1,000 invested in the&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), which tracks the S&amp;P 500 stock market index, would be worth $1,539.51 today. This marks a return of 54.0% over the last two years.
Each of the four cryptocurrencies and cryptocurrency platform Cramer criticized are up over the last two years with all but one beating the S&amp;P 500.&nbsp;Here&#8217;s a look at the returns for the other assets based on a $1,000 investment:
<ul>
<li>Ethereum:&nbsp;0.8150 ETH, $2,764.70 today, +176.5%</li>
<li>Litecoin:&nbsp;15.15 LTC, $1,528.79 today, +52.9%</li>
<li>Solana:&nbsp;82.78 SOL, $16,090.78 today, +1,509.1%</li>
<li>Coinbase:&nbsp;27.79 COIN, $7.076.45 today, +607.6%</li>
</ul>
Here&#8217;s a look at if an investor split the $1,000 evenly among the five assets shown to Cramer.
<ul>
<li>Bitcoin:&nbsp;$1,115.55</li>
<li>Ethereum: $552.94</li>
<li>Litecoin:&nbsp;$305.76</li>
<li>Solana:&nbsp;$3,218.16</li>
<li>Coinbase: $1,415.29</li>
<li>Total: $6,607.70, +560.8%</li>
</ul>
The $1,000 investment would be up 560.8% over the last two years, significantly beating the S&amp;P 500 and showing that the people who Cramer once called idiots may not be so dumb after all.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/24/12/42678116/if-you-gifted-your-family-100-in-bitcoin-dogecoin-and-ethereum-last-christmas-heres-how-much-they-would-have-this-christmas-2">If You Gifted Your Family $100 In Bitcoin, Dogecoin And Ethereum Last Christmas, Here&#8217;s How Much They Would Have This Christmas</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Education

Markets

$BTC

$ETH

$LTC

$SOL

COIN

If You Invested $1,000 In Bitcoin (And Other Crypto) When Jim Cramer Said Anyone Holding Was 'An Idiot', Here's How Much You'd Have Now

Old Dominion Freight Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) has outperformed the market over the past 5 years by 10.11% on an annualized basis producing an average annual return of 22.89%. Currently, Old Dominion Freight Line has a market capitalization of $37.85 billion. 
Buying $100 In ODFL: If an investor had bought $100 of ODFL stock 5 years ago, it would be worth $276.96 today based on a price of $177.28 for ODFL at the time of writing.
<h3>Old Dominion Freight Line's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735593307_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

ODFL

Here's How Much $100 Invested In Old Dominion Freight Line 5 Years Ago Would Be Worth Today

Pursuant to the SPA, the Purchasers agreed to purchase, severally and not jointly, and the Company agreed to issue and sell to the Purchasers, an aggregate of 15 million shares of the Company's common stock at a purchase price of $2.18 per share, for an aggregate purchase price of $32.70 million.

Offerings

SISI

Shineco Says On December 24, 2024, It Entered Into Securities Purchase Agreement With Nine Non-US Investors For Issue And Sale Of An Aggregate Of 15M Shares

It has closed a $25 million sale and bareboat agreement through its wholly owned subsidiary, Paralus Shipholding S.A., with an unrelated Japanese third party, with respect to the approximately 64,000 dwt bulk carrier "GLBS Magic" which was delivered from its builder, the Nantong Cosco Khi Ship Engineering Co., Ltd. shipyard in China on September 20, 2024.&nbsp;
At the end of the ten-year period, the Company has an obligation to buy back the vessel at a purchase price of $15.40 million, if not purchased earlier. The sale and bareboat charter back transaction closed on December 23, 2024. The bareboat charter contains certain covenants and agreements customary for financing agreements of this type.

Asset Sales

GLBS

Globus Maritime Says It Sold The GLBS Magic To An Unrelated Third Party For $25M; Has Bareboat Chartered Back The Vessel

In November, EastGroup acquired DFW Global Logistics Centre 5-8, four multi-tenant business distribution buildings totaling 492,000 square feet, for approximately $76 million.
In December, the Company acquired Akimel Gateway, which contains four industrial buildings totaling 519,000 square feet in Southeast Phoenix, for approximately $83 million.

EastGroup Properties Reveals Recent Business Activity; Recently Acquires Two Newer, Fully Leased, State Of The Art Properties Located Within Existing Submarkets

Elon Musk, who seems to love stirring the pot, is doing just that in Germany where elections are expected to be held on Feb. 23, 2025. The German government is accusing Musk&nbsp;of meddling in the election campaign with repeated endorsements of the country's far-right party .
"It is indeed the case that Elon Musk is trying to influence the federal election," said government spokesperson Christiane Hoffmann after various Musk X posts and an opinion piece published at the weekend backing the&nbsp;Alternative für Deutschland (AfD), <a href="https://www.theguardian.com/world/2024/dec/30/german-official-elon-musk-trying-to-influence-election-afd">noted</a> The Guardian.
Friedrich Merz, leader of Germany&#8217;s largest opposition party, said Musk&#8217;s interference was &#8220;intrusive and presumptuous,&#8221; and called it an unprecedented example of election interference between &#8220;friendly&#8221; countries.
<h1 class="wp-block-heading">Musk&#8217;s Myriad Interests In Germany</h1>
With Tesla's sprawling Gigafactory in Grünheide near Berlin, Musk's influence on Europe's largest economy has grown exponentially. It's hard to imagine he'd be indifferent to Germany's political landscape and how the election outcome will potentially shape policies that could benefit Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and other tech innovations.
Tesla's Gigafactory Berlin-Brandenburg, the first and <a href="https://www.benzinga.com/topic/giga-berlin" target="_blank" rel="noreferrer noopener">only gigafactory in Europe</a>, produces the Model Y and battery systems, solidifying Tesla's foothold in the lucrative European EV market. As of November 2024, it had produced more than 400,000 Model Y vehicles that were delivered to 37 countries and over 500,000 drive units at the factory.
Read Also: <a href="https://www.benzinga.com/tech/24/12/42717793/elon-musk-rejects-uk-as-a-possible-gigafactory-location">Elon Musk Rejects UK As A Possible Gigafactory Location</a>
Germany's political climate has further implications for financial markets, particularly German ETFs, which serve as barometers of economic sentiment. ETFs like iShares MSCI Germany (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWG#NYSE">EWG</a>), Global X DAX Germany (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAX#NASDAQ">DAX</a>), Franklin FTSE Germany (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLGR#NYSE">FLGR</a>) and First Trust Germany AlphaDEX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGM#NASDAQ">FGM</a>) reflect the health of Germany's industrial and automotive sectors, which are central to the nation's economy. Many of these ETFs include automotive giants such as Volkswagen (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>) and BMW (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMWKY#OTC">BMWKY</a>), companies with shifts towards EVs that intersect with Tesla's dominance.
Policy decisions surrounding green energy, emissions standards and labor laws could affect these ETFs. For instance, stricter environmental policies might accelerate the transition to EVs, benefiting Tesla while reshaping the competitive landscape for traditional automakers. On the flip side, Musk's advocacy for reduced red tape could bolster industries represented in ETFs, attracting both voter and investor interest.
Musk's potential influence in Germany's elections, whether through public statements or indirect lobbying, could also sway global investor sentiment. ETFs tied to Germany's economy are closely watched by international markets. And, as we know, political uncertainty has a way of creating market volatility.
Now Read:
<ul>
<li> <a href="https://www.benzinga.com/tech/24/12/42722137/elon-musk-peter-thiel-and-billionaires-influence-in-trumps-white-house-former-labor-secretary-robert-reichs-warning">Elon Musk, Peter Thiel And Billionaires&#8217; Influence In Trump&#8217;s White House: Former Labor Secretary Robert Reich&#8217;s Warning</a></li>
</ul>
Photo via Shutterstock.

Government

Eurozone

Economics

ETFs

BMWKY

FLGR

TSLA

VWAGY

Elon Musk Blasted As 'Intrusive And Presumptuous' For 'Trying To Influence' German Elections Toward Far-Right Party

CMPO

CompoSecure shares are trading higher after the company announced plans to spin off Resolute Holdings Management.

The Board's action aligns the company's formal name with the widespread practice over the past few years of referring to the company as "Gray Media" or simply "Gray" both internally and externally.
The name change does not affect the company's trading symbols, its CUSIPs, nor the rights of its security holders. The company anticipates that its common stock and Class A common stock will begin trading under its new name on January 10, 2025.

Gray Television Board Unanimously Votes To Change Company's Name To Gray Media, Inc. Effective January 1, 2025

<h3>Gainers</h3>
<ul>
<li>Nxu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXU#NASDAQ">NXU</a>) shares moved upwards by 270.2% to $0.9 during Monday's pre-market session. The market value of their outstanding shares is at $14.2 million. </li>
<li>Faraday Future (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) shares rose 31.77% to $2.32. The market value of their outstanding shares is at $105.1 million. </li>
<li>Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) shares moved upwards by 23.88% to $4.98. The market value of their outstanding shares is at $62.7 million. </li>
<li>Genius Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares rose 16.12% to $0.75. The company's market cap stands at $16.2 million. </li>
<li>Fly-E Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) shares rose 14.47% to $0.54. The market value of their outstanding shares is at $13.2 million. </li>
<li>Lottery.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) shares moved upwards by 9.89% to $0.57. The market value of their outstanding shares is at $5.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ambow Education Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMBO#AMEX">AMBO</a>) shares declined by 21.6% to $2.72 during Monday's pre-market session. The company's market cap stands at $7.7 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) stock declined by 13.87% to $0.87. The market value of their outstanding shares is at $248.9 million. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) shares declined by 10.64% to $2.1. The market value of their outstanding shares is at $1.2 million. </li>
<li>Raytech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAY#NASDAQ">RAY</a>) shares declined by 9.03% to $1.31. The company's market cap stands at $23.0 million. </li>
<li>ZSPACE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSPC#NASDAQ">ZSPC</a>) stock declined by 8.11% to $12.13. The market value of their outstanding shares is at $273.7 million. </li>
<li>Carriage Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSV#NYSE">CSV</a>) shares decreased by 7.22% to $37.01. The company's market cap stands at $561.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AMBO

FFIE

FLYE

LTRY

NWTN

VNCE

ZSPC

12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares increased by 65.2% to $2.71 during Monday's pre-market session. The market value of their outstanding shares is at $11.3 million. </li>
<li>Vincerx Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) stock moved upwards by 57.47% to $0.31. The market value of their outstanding shares is at $10.2 million. </li>
<li>Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) shares rose 42.43% to $0.53. The company's market cap stands at $29.1 million. </li>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) shares rose 39.39% to $4.6. The market value of their outstanding shares is at $8.1 million. </li>
<li>Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) shares moved upwards by 17.64% to $1.8. The company's market cap stands at $7.5 million. </li>
<li>Quoin Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNRX#NASDAQ">QNRX</a>) stock rose 15.29% to $0.63. The market value of their outstanding shares is at $5.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Traws Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRAW#NASDAQ">TRAW</a>) shares declined by 40.0% to $8.06 during Monday's pre-market session. The company's market cap stands at $24.3 million. </li>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) stock decreased by 29.97% to $0.42. The company's market cap stands at $26.8 million. </li>
<li>Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) shares declined by 13.64% to $0.38. The company's market cap stands at $27.4 million. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) stock fell 12.48% to $3.93. The company's market cap stands at $203.6 million. </li>
<li>Senseonics Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SENS#AMEX">SENS</a>) stock fell 10.66% to $0.53. The company's market cap stands at $314.9 million. </li>
<li>China Pharma Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CPHI#AMEX">CPHI</a>) stock declined by 9.91% to $0.19. The market value of their outstanding shares is at $3.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMIX

CPHI

MRNS

OTRK

PLRZ

QNRX

SENS

TRAW

VINC

XAIR

12 Health Care Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) shares increased by 213.6% to $1.27 during Monday's pre-market session. The company's market cap stands at $12.8 million. </li>
<li>Art's-Way Manufacturing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTW#NASDAQ">ARTW</a>) shares moved upwards by 38.52% to $3.38. The market value of their outstanding shares is at $17.0 million. </li>
<li>Stem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEM#NYSE">STEM</a>) stock increased by 37.65% to $0.82. The company's market cap stands at $133.2 million. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares moved upwards by 34.05% to $0.94. The company's market cap stands at $115.8 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) stock moved upwards by 26.73% to $1.28. The company's market cap stands at $187.8 million. </li>
<li>ClearSign Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIR#NASDAQ">CLIR</a>) stock rose 22.95% to $1.5. The market value of their outstanding shares is at $75.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lichen China (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) stock declined by 25.2% to $0.17 during Monday's pre-market session. The market value of their outstanding shares is at $8.3 million. </li>
<li>FTC Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTCI#NASDAQ">FTCI</a>) shares fell 13.54% to $4.58. The market value of their outstanding shares is at $58.5 million. </li>
<li>Nauticus Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) shares decreased by 13.43% to $1.87. The market value of their outstanding shares is at $11.9 million. </li>
<li>Graphex Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GRFX#AMEX">GRFX</a>) stock decreased by 11.11% to $0.39. The market value of their outstanding shares is at $22.6 million. </li>
<li>Vertical Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTL#NYSE">EVTL</a>) shares declined by 9.75% to $13.99. The market value of their outstanding shares is at $312.5 million. </li>
<li>Lavoro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVRO#NASDAQ">LVRO</a>) stock fell 9.23% to $4.38. The company's market cap stands at $510.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARTW

CLIR

EVTL

FTCI

GRFX

KITT

LICN

LVRO

STEM

WATT

12 Industrials Stocks Moving In Monday's Pre-Market Session

CompoSecure Tp Spin-Off Resolute Holdings Management, Announces Pro Rata Distribution Of Shares In Resolute Holdings To All Existing Shareholders Of Composecure

<h3>Gainers</h3>
<ul>
<li>Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) shares increased by 104.2% to $4.41 during Monday's pre-market session. The market value of their outstanding shares is at $38.4 million. </li>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock increased by 83.75% to $4.41. The market value of their outstanding shares is at $90.5 million. </li>
<li>Castellum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CTM#AMEX">CTM</a>) stock increased by 50.7% to $2.14. The company's market cap stands at $140.3 million. </li>
<li>Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) stock rose 46.2% to $1.9. The market value of their outstanding shares is at $178.3 million. </li>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) stock moved upwards by 35.43% to $0.48. The market value of their outstanding shares is at $1.4 million. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock moved upwards by 31.37% to $0.82. The company's market cap stands at $4.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) stock decreased by 18.4% to $5.31 during Monday's pre-market session. The company's market cap stands at $6.6 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock decreased by 17.24% to $1.69. The market value of their outstanding shares is at $15.4 million. </li>
<li>Infobird Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) shares decreased by 13.96% to $2.22. The market value of their outstanding shares is at $4.4 million. </li>
<li>SEALSQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) stock fell 11.68% to $8.02. The market value of their outstanding shares is at $629.9 million. </li>
<li>Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) stock fell 10.45% to $63.29. The company's market cap stands at $306.8 million. </li>
<li>Creative Global Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTL#NASDAQ">CGTL</a>) stock declined by 9.24% to $6.98. The company's market cap stands at $149.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CGTL

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IFBD

INTZ

LAES

LIDR

MYSZ

QMCO

REKR

12 Information Technology Stocks Moving In Monday's Pre-Market Session

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!



Moving stocks are new patents, insider buying, a company name change and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>PS International Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/psig-stock-quote/">PSIG</a>) stock is rocketing more than 81% alongside heavy pre-market trading.</li>



<li>Ainos (NASDAQ:<a href="https://investorplace.com/stock-quotes/aimd-stock-quote/">AIMD</a>) shares are soaring over 47% after <a href="https://www.nasdaq.com/press-release/ainos-secures-exclusive-multi-regions-invention-patent-licenses-strategic-partner">securing new patent licenses</a>.</li>



<li>LogicMark (NASDAQ:<a href="https://investorplace.com/stock-quotes/lgmk-stock-quote/">LGMK</a>) stock is surging more than 38% alongside details of an upcoming <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318511278&amp;type=PDF&amp;symbol=LGMK&amp;cdn=5653ec5b97d2382396937934a20579e2&amp;companyName=LogicMark+Inc.&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2024-08-09">special shareholder meeting</a>.</li>



<li>VS Media (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsme-stock-quote/">VSME</a>) shares are gaining over 25% despite a lack of news this morning.</li>



<li>Genius (NYSEMKT:<a href="https://investorplace.com/stock-quotes/gns-stock-quote/">GNS</a>) stock is increasing more than 19% <a href="https://www.nasdaq.com/press-release/genius-group-founder-ceo-roger-james-hamilton-purchase-10-million-shares-2024-08-09">on insider buying</a>.</li>



<li>FSD Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/huge-stock-quote/">HUGE</a>) shares are rising over 19% on <a href="https://www.nasdaq.com/press-release/fsd-pharma-announces-share-consolidation-and-name-change-2024-08-09">share consolidation and name change plans</a>.</li>



<li>ProMIS Neurosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/pmn-stock-quote/">PMN</a>) stock is climbing more than 17% this morning.</li>



<li>ConnectM Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/cntm-stock-quote/">CNTM</a>) shares are heading over 17% higher without any clear news today.</li>



<li>BioVie (NASDAQ:<a href="https://investorplace.com/stock-quotes/bivi-stock-quote/">BIVI</a>) stock is jumping more than 15% on Monday morning.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) shares are up over 14% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>iLearningEngines (NASDAQ:<a href="https://investorplace.com/stock-quotes/aile-stock-quote/">AILE</a>) stock is plummeting more than 27% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318511870&amp;type=PDF&amp;symbol=AILE&amp;cdn=8f0ca76b44522478ea48d6b3e52f5445&amp;companyName=iLearningEngines+Inc.&amp;formType=EFFECT&amp;formDescription=Notice+of+Effectiveness&amp;dateFiled=2024-08-09">pricing a public offering</a>.</li>



<li>Meta Materials (NASDAQ:<a href="https://investorplace.com/stock-quotes/mmat-stock-quote/">MMAT</a>) shares are diving over 17% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318508874&amp;type=PDF&amp;symbol=MMAT&amp;cdn=747b3fffafae953c1fe1c54f998009fd&amp;companyName=Meta+Materials+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-08-09">filing for bankruptcy</a>.</li>



<li>Sonoma Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/snoa-stock-quote/">SNOA</a>) stock is tumbling more than 15% after <a href="https://finance.yahoo.com/news/sonoma-pharmaceuticals-first-quarter-2025-120225512.html">missing fiscal Q1 2025 earnings estimates</a>.</li>



<li>Tenon Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/tnon-stock-quote/">TNON</a>) shares are taking an over 15% beating despite any clear news this morning.</li>



<li>Humacyte (NASDAQ:<a href="https://investorplace.com/stock-quotes/huma-stock-quote/">HUMA</a>) stock is sliding more than 13% <a href="https://www.stocktitan.net/news/HUMA/humacyte-announces-fda-communication-of-additional-time-required-to-5oxy7ry3qlgj.html">on an update</a> from the Food and Drug Administration (FDA).</li>



<li>Aditxt (NASDAQ:<a href="https://investorplace.com/stock-quotes/adtx-stock-quote/">ADTX</a>) shares are falling over 12% on a <a href="https://www.nasdaq.com/press-release/aditxt-announces-12-million-registered-direct-offering-priced-market-under-nasdaq">registered direct offering</a>.</li>



<li>CareMax (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmax-stock-quote/">CMAX</a>) stock is dropping close to 12% on a <a href="https://finance.yahoo.com/news/caremax-inc-cmax-reports-q2-224503059.html">Q2 loss and revenue miss</a>.</li>



<li>Big Tree Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/dsy-stock-quote/">DSY</a>) shares are decreasing more than 10% <a href="https://www.nasdaq.com/press-release/big-tree-cloud-holdings-limited-receives-nasdaq-notification-regarding-minimum-market">with a delisting notice</a>.</li>



<li>Azitra&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/aztr-stock-quote/">AZTR</a>) stock is slipping over 10% this morning.</li>



<li>Bright Minds Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/drug-stock-quote/">DRUG</a>) shares close out our pre-market stock movers down more than 10% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-aug-12th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Ainos&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/aimd-stock-quote/">AIMD</a>) stock is heading higher on Monday after the medical technologies development company <a href="https://finance.yahoo.com/news/ainos-secures-exclusive-multi-regions-201500321.html">secured new patent licenses</a>.



According to a press release from Ainos, the company has obtained exclusive licenses for 10 patents from Taiwan Carbon Nano Technology. This is Ainos&rsquo; affiliate&nbsp;and product co-developer.



Ainos&nbsp;notes that the patents in this agreement are tied to gas sensors and medical devices. These patents cover multiple regions including the U.S., Germany, China, Japan and Taiwan.



The company also mentions that it acquired them from Taiwan Carbon Nano Technology in exchange for AIMD stock. This saw it issue shares worth $5.4 million to cover the acquisition of the patent licenses.



Chun-Hsien Tsai, chairman, president and CEO of Ainos, said the following about the deal.




&ldquo;I believe this licensing will bolster our AI Nose and POCT technologies as we advance our AI Nose and POCT pipeline, including progressing our leading volatile organic compounds (&ldquo;VOC&rdquo;) POCT candidate, Ainos Flora, and jointly developing a VOC sensing platform with our Japanese partners.&rdquo;




<h2>AIMD Stock Movement Today</h2>



With this news comes heavy trading of AIMD stock this morning. That has more than 9 million units on the move as of this writing. That&rsquo;s well above its daily average trading volume of about 793,000 shares.



AIMD stock is up 37.9% as of Monday morning.



There are even more stock market stories worth reading about today below!



We have all of the hottest stock market stories that traders need to know about on Monday! Among that is what has shares of PS International Group&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/psig-stock-quote/">PSIG</a>) stock up today, the biggest pre-market stock movers this morning and more. All of this info is ready to go at the links below!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2024/08/why-is-ps-international-psig-stock-up-64-today/">Why Is PS International (PSIG) Stock Up 64% Today?</a></li>



<li><a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-aug-12th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>



<li><a href="https://investorplace.com/2024/08/what-archer-aviation-achr-stock-investors-should-know-about-the-los-angeles-air-taxi-news/">What Archer Aviation (ACHR) Stock Investors Should Know About the Los Angeles Air Taxi News</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/why-is-ainos-aimd-stock-up-38-today/">Why Is Ainos (AIMD) Stock Up 38% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Ainos (AIMD) Stock Up 38% Today?

Ainos (AIMD) has secured exclusive licensing rights for an additional 28 multi-regional patent assets from its strategic shareholder and product co...

Ainos secures exclusive licensing rights for 28 patent assets

Ainos reports Q3 results

Ainos (AIMD) has received Institutional Review Board approval from Shuang Ho Hospital, affiliated with Taipei Medical University, for its clinical ...

Ainos announces IRB approval for Sjogren's Syndrome clinical study

Ainos Inc ( ($AIMD) ) has released its Q3 earnings. Here is a breakdown of the information Ainos Inc presented to its investors. Ainos, Inc. is a d...

Ainos, Inc. Reports Q3 Financial Results and Strategic Developments

Ainos ( ($AIMD) ) has provided an announcement. Ainos, Inc. has announced a strategic collaboration with Taiwan Tanabe Seiyaku to enhance the produ...

Ainos Partners with Taiwan Tanabe for VELDONA® Expansion

Ainos (AIMD) announced its participation in the Webull Corporate Connect Service. This initiative aims to further expand the Company's investor out...

Ainos joins Webull Corporate Connect Service platform

Ainos (AIMD) provided a letter to shareholders from its Chairman, President, and CEO Chun-Hsien Tsai, which read in part, "As 2024 draws to a close...

Ainos CEO looks to advance AI nose technology in 2025

06:22 EST Ainos (AIMD) files to sell 6.74M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market...

Ainos files to sell 6.74M shares of common stock for holders

ADTX

AILE

AIMD

AZTR

BIVI

CMAX

CNTM

DRUG

HUGE

HUMA

LGMK

MMAT

PRTG

PSIG

SNOA

TNON

VSME

Press Releases

Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

Ainos Expands Patent Portfolio With Strategic Shareholder's Cutting-Edge Technology Assets

Ainos Reports Third Quarter 2024 Financial Results

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities

Ainos Announces IRB Approval for Sjögren's Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments

Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Comments

Ainos

Ainos (AIMD) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL